Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation

Clinical Transplantation

Volumn 17, Issue 5, 2003, Pages 477-483

  van der Mast, Barbara J ^a   van den Dorpel, Marinus A ^b   Drabbels, Jos J M ^c   Claas, Frans H J ^c   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Medisch Centrum Rijnmond Zuid   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Kidney transplantation; TA GVHD; Transfusion

Indexed keywords

GENTAMICIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMIPENEM; METHYLPREDNISOLONE;

ADULT; ARTICLE; BLOOD DONOR; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; IMMUNOREACTIVITY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEUKOCYTE TRANSFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; BLOOD GROUP INCOMPATIBILITY; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HUMANS; KIDNEY TRANSPLANTATION; LEUKOCYTE TRANSFUSION; LIVING DONORS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 0141955817     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00074.x     Document Type: Article

References (22)

1. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease [published erratum appears in N Engl J Med 1990 Nov 8;323(19):1360]. N Engl J Med 1990: 323(5): 315.
2. Spitzer TR, Cahill R, Cottler-Fox M, Treat J, Sacher R, Deeg HJ. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature. Cancer 1990: 66(11): 2346.
3. Sakakibara T, Juji T. Post-transfusion graft-versus-host disease after open heart surgery [letter]. Lancet 1986: 2(8515): 1099.
4. Suzuki K, Akiyama H, Takamoto S et al. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells. Transfusion 1992: 32(4): 358.
5. Shivdasani RA, Haluska FG, Dock NL, Dover JS, Kineke EJ, Anderson KC. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med 1993: 328(11): 766.
6. Ahya R, Douglas JG, Watson HG. Transfusion-associated graft-versus-host disease in an immunocompetent individual following coronary artery bypass grafting. Heart 1998: 80(3): 299.
7. Rososhansky S, Badonnel MC, Hiestand LL, Popovsky MA, Szymanski IO. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery. Vox Sang 1999: 76(1): 59.
8. Gorman TE, Julius CJ, Barth RF et al. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor. Am J Clin Pathol 2000: 113(5): 732.
9. Kita T, Nei J, Matsu T et al. GVHD after transfusion of stored RBC concentrates in a solution of mannitol, adenine, phosphate, citrate, glucose, and NaCl following trauma. Transfusion 2000: 40(3): 297.
10. Greenbaum BH. Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products [see comments]. J Clin Oncol 1991: 9(10): 1889.
11. Brubaker DB. Human posttransfusion graft-versus-host disease. Vox Sang 1983: 45(6): 401.
12. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990: 30(7): 583.
13. Verduyn W, Doxiadis, II, Anholts J et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 1993: 37(1): 59.
14. Strijbosch LWG, Buurman WA, Does RJM, Zinken P, Groenewegen G. Limiting dilution assays: experimental design and statistical analysis. J Immunol Methods 1987: 97: 133.
15. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheimvan Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990: 28(3): 495.
16. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR- SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39(5): 225.
17. Kosmatopoulos K, Scott-Algara D, Orbach-Arbouys S, Halle-Pannenko O. Specific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. Role of cytotoxic T lymphocytes directed against receptors for the major histocompatibility complex. Transplantation 1988: 46(4): 570.
18. Ohto H, Anderson KC. Posttransfusion graft-versus-host disease in Japanese newborns. Transfusion 1996: 36(2): 117.
19. Wagner FF, Flegel WA. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion 1995: 35(4): 284.
20. Ohto H, Yasuda H, Noguchi M, Abe R. Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives. Transfusion 1992: 32(7): 691.
21. Ohto H, Anderson KC. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 1996: 10(1): 31.
22. Vogelsang GB. Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts. Transfusion 1990: 30(2): 101.